Non-Transitional Cell Carcinoma of the Urothelial Tract
1 clinical trials · Condition
◉ Watch Non-Transitional Cell Carcinoma of the Urothelial Tract
| Record | Firm | Date |
|---|---|---|
| Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract (NCT03430895) | Memorial Sloan Kettering Cancer Center | 2018-01-31 |
Track Non-Transitional Cell Carcinoma of the Urothelial Tract automatically
Every clearance here is in the API, with alerts when new ones post.